Navigation Links
Corgenix Reports Second Quarter Fiscal 2009 Financial Results
Date:2/12/2009

- Revenues for the quarter decrease 17% vs. prior year -

DENVER, Feb. 12 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, today filed its 2nd quarter Form 10-Q and reported financial results. The report disclosed that the company's sales and operating results have declined during the quarter and six months ended December 31, 2008. Some of the results highlighted by the report are as follows:

  • Revenues for the quarter decreased $404,012 or 16.8% vs. the prior year's comparable quarter; of this, $179,365 was a reduction in contract manufacturing revenue primarily due to reduced sales to one key customer as previously reported.
  • Total operating expenses increased $88,345 or 7.9% vs. the prior year's comparable quarter.
  • Operating loss for the quarter was $56,223 vs. an operating income of $224,224 for the prior year's comparable quarter.
  • Net loss increased to $268,374 in the current quarter from $60,310 in the prior year's comparable quarter.

"The decline in our revenues continues to demonstrate the weakness in our contract manufacturing sector as previously reported," said Douglass Simpson, President and CEO of Corgenix. "Excluding contract manufacturing revenue, our six month revenues declined approximately 3.5% over the same period in the prior year which we believe is largely related to the slowdown of the overall economy. We are continuing to aggressively seek opportunities to grow our business in contract manufacturing as well as our core products including the AspirinWorks Test."

The company noted that the financial performance for the quarter was weak, with weakness in core product revenue and increased net negative cash flow. The company expects that Fiscal Year 2009 revenues will approximate that o
'/>"/>

SOURCE Corgenix Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Corgenix Signs Technology Licensing Agreement With Japanese Government
2. Corgenix to Exhibit AspirinWorks(R) Test at ACC 2008 Meeting in Chicago
3. Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit
4. Corgenix to Host Conference Call to Discuss Third Quarter Fiscal 2008 Results
5. Corgenix to Exhibit AspirinWorks(R) Test at ADA 2008 Meeting in San Francisco
6. Corgenix Expands Scientific Advisory Board
7. Corgenix to Host Conference Call to Discuss Fiscal 2008 Results
8. Corgenix Reports Fiscal 2008 Financial Results
9. Corgenix Receives Third U.S. Patent on AtherOx(R) Technology
10. Corgenix to Exhibit AspirinWorks(R) Test, Discuss New CHARISMA Trial Results at AHA 2008 Meeting
11. Corgenix to Host Conference Call to Discuss First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Richardson, Texas (PRWEB) October 20, 2014 ... today announced that a team from Iowa State University ... * design contest. Using a Convey HC-2ex, the team’s ... than 14 times faster than the second place finisher. ... academic world embarked upon the month long challenge, using ...
(Date:10/20/2014)... Oct. 20, 2014  GenVec, Inc. (NASDAQ: GNVC ... , Ph.D., from its board of directors effective on October ... 2003, and served as its chairman from June 2006 to ... Nominating and Corporate Governance and Audit Committees of the board.  ... a decade of dedicated service to GenVec, and its stockholders," ...
(Date:10/20/2014)... 2014 Local veterinary surgeon, Dr. Tim ... study of donor stem cells for dogs with osteoarthritis. ... and has performed clinical stem cell therapy for 7 ... determine if a single injection of donor stem cells ... reduce pain and inflammation in the treated joints. ...
(Date:10/19/2014)... The Asia-Pacific Bromine Market report defines ... analysis and forecast of revenue. , Browse through ... report, to get an idea of the in-depth ... the segmentation in the Asia-Pacific bromine market, and ... , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , Bromine is a ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3Zola P. Horovitz To Retire From GenVec Board 2Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3
... (OTC Bulletin Board: BNET) announced that notification was received,today ... System" has been granted by the Commonwealth of Australia,Patent ... The,official filing date is approved as November 8, 2001 ... date of November 8, 2021., This patent now ...
... N.J., Sept. 25 Osteotech, Inc.,(Nasdaq: OSTE ), ... for,regenerative medicine, announced today the appointment of Cato T.,Laurencin, ... joined the,Board of Directors effective September 24, 2008 and ... of the Board of Directors., Kenneth P. Fallon, ...
... Vanda,Pharmaceuticals Inc. (Nasdaq: VNDA ), a ... of clinical-stage product candidates,for central nervous system ... of Vanda Pharmaceuticals Inc. (the "Company") declared ... Right (a "Right") on each,outstanding share of ...
Cached Biology Technology:Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment 2Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors 2Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights 2Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights 3
(Date:10/18/2014)... Berlin, 19th October 2014 Psychological stress and stress-related ... for aging-related diseases, but the molecular mechanisms ... mechanisms may contribute to the development of ... treatments for these devastating diseases. This work ... Neuropsychopharmacology congress in Berlin., Now an international ...
(Date:10/17/2014)... of Copenhagen have shown for the first time how ... fibrosis patients, giving them the opportunity to get tremendous ... , The study also discovered the bacterial growth in ... halted or slowed down by the immune cells. The ... and helped "suffocate" the bacteria, forcing the bacteria to ...
(Date:10/16/2014)... how the bowel lining develops and, in the process, ... , The researchers produced evidence that stem cells are ... a feature of the bowel lining, and believe these ... controversial finding as scientists are still divided on the ... Chin Wee Tan and Professor Tony Burgess from the ...
Breaking Biology News(10 mins):Researchers find why depression and aging linked to increased disease risk 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Cryptic clues drive new theory of bowel cancer development 2
... Plant Science Center (PSC) have clarified a key epigenetic ... Arabidopsis protects cells from harmful DNA elements. Published in ... Genetics , the finding contributes to advancing our understanding ... plants and animals, opening the door to applications in ...
... Professor Cyrus Cooper, Professor of Rheumatology and Director ... has been awarded the Heberden Medal of the British ... Musculoskeletal Research Programme at the University of Southampton for ... 2003. His research programme has focused on ...
... WASHINGTONA bill in Oregon that would provide incentives to deliver ... the state,s residents and, at the same time, create hundreds ... according to a study released by Upstream Public Health in ... Health Impact Project, a collaboration of the Robert Wood Johnson ...
Cached Biology News:Discovery of DNA silencing mechanism reveals how plants protect their genome 2Oregon Farm to School bill would benefit health through job creation, study finds 2Oregon Farm to School bill would benefit health through job creation, study finds 3
... positive control for ChIP assays. Efficient fixation ... is a crucial step for the Chromatin-immunoprecipitation ... probably the most important parameter. Two major ... be taken into account: first, an excess ...
Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
The Programmable MP-5000P-F Power Supply can be applied for any Microfluidic application....
Rab GDP dissociation inhibitor beta...
Biology Products: